Chronic Exposure of Human Endothelial Progenitor Cells to Diabetic Condition Abolished the Regulated Kinetics Activity of Exosomes

By virtue of lifestyle change, incidence of diabetes mellitus type 2 is increasingly being raised with different up-surging pathologies. It was showed that endothelial progenitor cells (EPCs) were disqualified in neo-angiogenesis induction. Besides, to an aborted differentiation property, malfunctioned paracrine activities worsen off vascular abnormality. Nano-scaled exosomes play essential roles in reciprocal cell-cell crosstalk via bioactive molecules. To address the effect of diabetic serum on exosome secretion capacity, EPCs were exposed to diabetic condition for seven days. In addition to in-vitro tubulogenesis, migration and LDL uptake assessment, exosome release capacity, and expression profiles of three genes participating in exosome kinetics, including CD63, Alix and Rab27a, revealed by Real-time PCR method. Data showed diabetic sera not only abolished the in-vitro tubulogenesis, migration and LDL uptake properties but also decreased exosome release and expression of related genes. This study sheds lights on the adverse effect of diabetic condition on exosome kinetics in EPCs.

[1]  R. Rahbarghazi,et al.  ECM‐Dependence of Endothelial Progenitor Cell Features , 2016, Journal of cellular biochemistry.

[2]  Jianhong Wu,et al.  Identification and analysis of exosomes secreted from macrophages extracted by different methods. , 2015, International journal of clinical and experimental pathology.

[3]  Jun-Lin Jiang,et al.  Accelerated onset of senescence of endothelial progenitor cells in patients with type 2 diabetes mellitus: role of dimethylarginine dimethylaminohydrolase 2 and asymmetric dimethylarginine. , 2015, Biochemical and biophysical research communications.

[4]  R. Tanaka,et al.  Introduction to next generation of endothelial progenitor cell therapy: a promise in vascular medicine. , 2015, American journal of translational research.

[5]  C. Magnan,et al.  Glucolipotoxicity Impairs Ceramide Flow from the Endoplasmic Reticulum to the Golgi Apparatus in INS-1 β-Cells , 2014, PloS one.

[6]  R. Fernandes,et al.  Reduced levels of circulating endothelial progenitor cells in acute myocardial infarction patients with diabetes or pre-diabetes: accompanying the glycemic continuum , 2014, Cardiovascular Diabetology.

[7]  F. Pattou,et al.  MST1 is a key regulator of beta cell apoptosis and dysfunction in diabetes , 2014, Nature Medicine.

[8]  Clotilde Théry,et al.  Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles , 2013, Journal of Cell Science.

[9]  U. Narayanan,et al.  Chronic glucolipotoxic conditions in pancreatic islets impair insulin secretion due to dysregulated calcium dynamics, glucose responsiveness and mitochondrial activity , 2013, BMC Cell Biology.

[10]  S. Bornstein,et al.  Current Aspects in the Pathophysiology and Treatment of Chronic Wounds in Diabetes Mellitus , 2013, BioMed research international.

[11]  Ian A. White,et al.  Impaired Endothelial Progenitor Cell Mobilization and Dysfunctional Bone Marrow Stroma in Diabetes Mellitus , 2013, PloS one.

[12]  A. Modarressi,et al.  Hyperglycemia Increases Susceptibility to Ischemic Necrosis , 2012, BioMed research international.

[13]  Ylva Ivarsson,et al.  Syndecan–syntenin–ALIX regulates the biogenesis of exosomes , 2012, Nature Cell Biology.

[14]  D. Sabatini,et al.  mTOR Signaling in Growth Control and Disease , 2012, Cell.

[15]  F. Booth,et al.  Lack of exercise is a major cause of chronic diseases. , 2012, Comprehensive Physiology.

[16]  C. Théry,et al.  Diverse subpopulations of vesicles secreted by different intracellular mechanisms are present in exosome preparations obtained by differential ultracentrifugation , 2012, Journal of extracellular vesicles.

[17]  Clotilde Théry,et al.  Exosome Secretion: Molecular Mechanisms and Roles in Immune Responses , 2011, Traffic.

[18]  H. Masuda,et al.  R EGENERATIVE M EDICINE Concise Review: Circulating Endothelial Progenitor Cells for Vascular Medicine , 2022 .

[19]  H. Perlman,et al.  Exosomes From Human CD34+ Stem Cells Mediate Their Proangiogenic Paracrine Activity , 2011, Circulation research.

[20]  P. Altevogt,et al.  Body fluid derived exosomes as a novel template for clinical diagnostics , 2011, Journal of Translational Medicine.

[21]  Cheng Zhang,et al.  Circulating endothelial progenitor cells and cellular membrane microparticles in db/db diabetic mouse: possible implications in cerebral ischemic damage. , 2011, American journal of physiology. Endocrinology and metabolism.

[22]  Taoyong Chen,et al.  Chemokine-Containing Exosomes Are Released from Heat-Stressed Tumor Cells via Lipid Raft-Dependent Pathway and Act as Efficient Tumor Vaccine , 2011, The Journal of Immunology.

[23]  M. Frid,et al.  Progenitor cells in pulmonary vascular remodeling , 2011, Pulmonary circulation.

[24]  M. Grant,et al.  The promise of cell-based therapies for diabetic complications: challenges and solutions. , 2010, Circulation research.

[25]  N. Hamburg,et al.  Endothelial dysfunction in diabetes mellitus: Molecular mechanisms and clinical implications , 2010, Reviews in Endocrine and Metabolic Disorders.

[26]  S. Lim,et al.  Hypoxic Tumor Cell Modulates Its Microenvironment to Enhance Angiogenic and Metastatic Potential by Secretion of Proteins and Exosomes* , 2010, Molecular & Cellular Proteomics.

[27]  Biao Xu,et al.  Advanced glycation end products impair function of late endothelial progenitor cells through effects on protein kinase Akt and cyclooxygenase-2. , 2009, Biochemical and biophysical research communications.

[28]  J. Marine,et al.  Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice , 2008, Cell Death and Differentiation.

[29]  L. Dimeglio,et al.  In Vitro Hyperglycemia or a Diabetic Intrauterine Environment Reduces Neonatal Endothelial Colony-Forming Cell Numbers and Function , 2008, Diabetes.

[30]  F. Ashcroft,et al.  Long-Term Exposure to Glucose and Lipids Inhibits Glucose-Induced Insulin Secretion Downstream of Granule Fusion With Plasma Membrane , 2007, Diabetes.

[31]  Po-Len Liu,et al.  High Glucose Impairs Early and Late Endothelial Progenitor Cells by Modifying Nitric Oxide–Related but Not Oxidative Stress–Mediated Mechanisms , 2007, Diabetes.

[32]  Peter Carmeliet,et al.  VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  Nils Welsh,et al.  Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. , 2005, Diabetes.

[34]  S. Dimmeler,et al.  Endothelial Progenitor Cells: Characterization and Role in Vascular Biology , 2004, Circulation research.

[35]  J. Olzmann,et al.  High glucose‐induced oxidative stress and mitochondrial dysfunction in neurons , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  Patrice Darmon,et al.  Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. , 2002, Diabetes.

[37]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[38]  H. Daida,et al.  The role of Notch signaling in diabetic endothelial progenitor cells dysfunction. , 2016, Journal of diabetes and its complications.

[39]  Xiaohong Wang,et al.  Pathologic function and therapeutic potential of exosomes in cardiovascular disease. , 2015, Biochimica et biophysica acta.

[40]  Miguel C. Seabra,et al.  1 Rab 27 a and Rab 27 b control different steps of the exosome secretion pathway , 2009 .

[41]  C. Liang,et al.  Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways , 2008, Basic Research in Cardiology.

[42]  M. Blombäck,et al.  Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers. , 2007, Thrombosis research.

[43]  Geoffrey C Gurtner,et al.  Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia. , 2003, The American journal of pathology.

[44]  M. Vidal,et al.  Exosomes released during reticulocyte maturation bind to fibronectin via integrin α4β1 , 2000 .